v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents ($320 and $328 related to VIEs) $ 2,923 $ 2,135
Marketable securities ($26 and $39 related to VIEs) 120 59
Accounts receivable, net ($134 and $142 related to VIEs) 1,027 1,073
Contract assets ($55 and $17 related to VIEs) 1,440 1,146
Investment in NuScale 0 1,579
Other current assets ($17 and $26 related to VIEs) 184 450
Total current assets 5,694 6,442
Noncurrent assets    
PP&E, net ($40 and $41 related to VIEs) 446 464
Investments 548 543
Other assets ($7 and $17 related to VIEs) 848 787
Total noncurrent assets 1,842 1,794
Total assets 7,536 8,236
Current liabilities    
Accounts payable ($142 and $205 related to VIEs) 1,762 1,482
Contract liabilities ($163 and $254 related to VIEs) 541 633
Accrued salaries, wages and benefits ($11 and $9 related to VIEs in both periods) 571 621
Other accrued liabilities ($24 and $31 related to VIEs) 296 642
Total current liabilities 3,170 3,378
Long-term debt 1,072 1,070
Deferred taxes 5 6
Other noncurrent liabilities ($4 and $3 related to VIEs) 504 505
Commitments and contingencies
Shareholders’ equity    
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 135,564,463 and 152,047,739 shares in 2026 and 2025, respectively 1 2
APIC 0 443
AOCI (293) (265)
Retained earnings 2,978 3,064
Total shareholders’ equity 2,686 3,244
NCI 99 33
Total equity 2,785 3,277
Total liabilities and equity $ 7,536 $ 8,236